Despite advancements in drug-eluting stents, in-stent restenosis (ISR) remains a challenge for percutaneous coronary intervention (PCI), resulting in high rates of recurrence despite various interventions. Although percutaneous approaches, such as balloon angioplasty, rotational atherectomy, and...